+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years +
All Genders
ID06785519

Study of CD19BCMA CAR-T Cell Therapy Safety and Effectiveness for Adults with Refractory or Relapsed Lupus Nephritis

Led by He Huang · Updated on 2025-01-21

9

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and effectiveness of CD19BCMA CAR-T cell therapy for patients with refractory or relapsed lupus nephritis, a severe kidney condition caused by systemic lupus erythematosus SLE. The study builds on previous findings that clarified the therapys safety and seeks to further observe its impact while expanding the number of participants to gather more safety data. Nine patients with relapsed refractory lupus nephritis are planned to take part in this early phase 1 clinical trial. Participants will receive an intravenous infusion of CD19BCMA targeted CAR T-cells designed specifically to treat lupus nephritis. The therapy is administered as a single treatment following careful evaluation. This interventional study does not use masking or blinding, and all participants will undergo the same treatment. The study period includes treatment administration and long-term follow-up to monitor outcomes and safety. During the study, participants will be closely monitored for dose-limiting toxicities and treatment-emergent adverse events for up to 28 years and 2 years respectively after treatment. Researchers will also measure urinary protein levels shortly after treatment to assess kidney function. Safety assessments and disease activity evaluations will occur throughout the study. Participants must agree to use contraception during the study and for six months afterward. The total participation duration varies depending on individual follow-up needs.

CONDITIONS

Brief Title

CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis

Research Team

H

He Huang, MD

Y

Yongxian Hu, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here